
Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization
Author(s) -
Ellina Lytvyak,
Promoting Access,
Reed T. Sutton,
Levinus A. Dieleman,
Farhad Peerani,
Richard N. Fedorak,
Karen I. Kroeker
Publication year - 2020
Publication title -
crohn's and colitis 360
Language(s) - English
Resource type - Journals
ISSN - 2631-827X
DOI - 10.1093/crocol/otaa080
Subject(s) - emergency department , medicine , inflammatory bowel disease , incidence (geometry) , care pathway , managed care , emergency medicine , rate ratio , disease , disease management , intensive care medicine , health care , confidence interval , parkinson's disease , optics , economics , economic growth , physics , psychiatry
Background Standardizing care through pathways has the potential to reduce emergency department (ED) utilization. We developed and evaluated inflammatory bowel disease (IBD) care pathways for that purpose. Methods Over 2014–2016, IBD patients were retrospectively stratified into those managed and not managed by pathways. Patient data were extracted, and negative binomial regression used to predict the annual number of ED visits. Results There was a difference of 30.7 ED visits/100 patients between managed and nonmanaged at 12 months (P < 0.001). The incidence rate ratio of total ED visits occurring annually was 0.750 (P = 0.008). Conclusions Management with IBD care pathways reduces ED utilization.